Cytokinetics EVP R&D Malik Fady Ibraham disposes of common shares worth $239,015 - CYTK News | RalliesCytokinetics EVP R&D Malik Fady Ibraham disposes of common shares worth $239,015
C
CYTK• Insider share transaction
- Cytokinetics EVP Research & Development Malik Fady Ibraham exercised stock options for 3,500 shares at USD 7.8 on Sept. 22, 2026.
- He sold 3,500 shares the same day at USD 68.29.
- Directly held common stock ended unchanged at 153,902 shares.
- Non-qualified stock options held fell to 23,386.
